Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
Conditions: Advanced Gastric Cancer Interventions: Procedure: Fecal Microbiota Transplantation Capsules; Procedure: Placebo Sponsors: Xiangyu Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Molecular Assessment for Gastro-Esophageal Cancer
Conditions: Esophageal Cancer; Gastric Cancer; Barrett Esophagus Interventions: Diagnostic Test: Breath analysis; Diagnostic Test: Blood analysis Sponsors: KU Leuven Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment
Conditions: Esophageal Cancer; Gastric Cancer Interventions: Other: Survey Sponsors: KU Leuven Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs
Conditions: Gastro-entero-pancreatic Neuroendocrine Tumor Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
The Value of End-tidal Capnography in Gastrointestinal Bleeding
Conditions: Patients Presenting to the Emergency Department; Gastro Intestinal Bleeding Interventions: Device: End-tidal capnography Sponsors: Izmir Katip Celebi University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Cessation of Somatostatin Analogues After PRRT in Mid-Gut Neuroendocrine Tumours
Conditions: Neuroendocrine Tumors Interventions: Drug: Cessation of somatostatin analogues; Drug: Continuation of somatostatin analogues Sponsors: Australasian Gastro-Intestinal Trials Group; Canadian Cancer Trials Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
Conditions: Breast Cancer; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma Interventions: Drug: AB-201; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: GC Cell Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
Conditions: Gastric Cancer; Gastric Cancer Metastatic to Regional Lymph Nodes Interventions: Drug: Sintilimab; Radiation: Extraperitoneal radiation therapy; Drug: Oxaliplatin; Drug: S-1 Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Stomach Cancer Exosome-based Detection
Conditions: Gastric Cancer; Gastric Adenocarcinoma; Gastric Cancer Stage; Gastric Neoplasm; Gastric Lesion; Gastric Cancer in Situ; Gastric Cancer Stage IV; Gastric Cancer Stage IIIB; Gastric Cancer Stage III; Gastric Cancer Stage IB; Gastric Cancer Stage IA; Gastric Cancer, Stage 0; Gastric Cancer Stage IIIA; Gastric Cancer Stage II; Gastric Cancer TNM Staging; Gastric Cancer Metastatic to Lung; Gastric Cancer Metastatic to Liver; Gastric Cancer Stage I; Gastric Cancer TNM Staging Primary Tumor (T) T2B Interventions: Diagnostic Test: DESTINEX Sponsors: City of Hope Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma
Conditions: Gastric and Gastroesophageal Junction Adenocarcinoma Interventions: Drug: cadonilimab; Drug: pulocimab; Drug: paclitaxel; Drug: placebo Sponsors: Akeso Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Lymphocyte Enhancement in Gastroenteric Oncology
Conditions: Advanced Gastrointestinal Cancers Interventions: Dietary Supplement: EAA supplementation; Other: Isocaloric placebo Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia; University of Pavia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study
Conditions: Diabetic Gastroparesis; Diabetic Gastropathy; Diabetic Gastroenteropathy; Diabetic Gastroparesis Associated With Type 2 Diabetes Mellitus Interventions: Other: Washing Microbiota Transplantation Sponsors: The Second Hospital of Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
The Effects of Acupressure on Pain and Gastrointestinal Fuctions in Women Underwent Hysterectomy
Conditions: Pain Management; Hysterectomy; Vomiting Interventions: Other: Acupressure Sponsors: Istanbul Medipol University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Conditions: Esophageal Adenocarcinoma; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma Interventions: Drug: OBP-301; Drug: Pembrolizumab Sponsors: Weill Medical College of Cornell University; Merck Sharp& Dohme LLC; Oncolys BioPharma Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients
Conditions: Predictive Cancer Model; Gastric Cancer; Lymph Node Metastasis Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
